# Bio Impedance Monitoring as a Tool to Assess Fluid Status in the Pediatric Surgical Patient? (PedFluid Study)

> **NCT05220709** · NA · RECRUITING · sponsor: **University Hospital, Antwerp** · enrollment: 100 (estimated)

## Conditions studied

- Fluid and Electrolyte Imbalance
- Body Weight Changes
- Children, Only

## Interventions

- **DIAGNOSTIC_TEST:** bio impedance spectroscopy by means of the Body Composition Monitor (Name of the device is BCM from Fresenius Medical Care D GmbH)

## Key facts

- **NCT ID:** NCT05220709
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-05
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-05-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05220709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05220709, "Bio Impedance Monitoring as a Tool to Assess Fluid Status in the Pediatric Surgical Patient? (PedFluid Study)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05220709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*